New drug aims to fortify immune system after brain cancer treatment
NCT ID NCT03687957
Summary
This study is testing whether a new drug called rhIL-7-hyFc can safely increase the number of infection-fighting white blood cells in people with aggressive brain tumors. The trial involves 42 patients who have already received standard radiation and chemotherapy. The main goal is to see if the drug helps restore the immune system, which is often weakened by cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.